Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.
<h4>Background</h4>The unique responsiveness of Vgamma9Vdelta2 T-cells, the major gammadelta subset of human peripheral blood, to non-peptidic prenyl pyrophosphate antigens constitutes the basis of current gammadelta T-cell-based cancer immunotherapy strategies. However, the molecular me...
Main Authors: | Daniel V Correia, Francisco d'Orey, Bruno A Cardoso, Telma Lança, Ana R Grosso, Ana deBarros, Leila R Martins, João T Barata, Bruno Silva-Santos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-05-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19479075/?tool=EBI |
Similar Items
-
Combination therapies to inhibit the RAF/MEK/ERK pathway in melanoma: we are not done yet.
by: Grant A. McArthur
Published: (2015-07-01) -
Synthesis of phosphoantigens and chiral trisphosphonates
by: Shippy, Rebekah Ruth
Published: (2016) -
Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway.
by: Vijay Ramakrishnan, et al.
Published: (2012-01-01) -
Monitoring circulating gammadelta T cells in cancer patients to optimize gammadelta T cell-based immunotherapy
by: Hans-Heinrich eOberg, et al.
Published: (2014-12-01) -
Development of Dual-Pathway Inhibitors of Raf/MEK/ERK and PI3K/Akt Signaling Pathways.
by: Fraser, Sasha
Published: (2011)